Investors with an eye on the healthcare sector may find Establishment Labs Holdings Inc (NASDAQ: ESTA) an intriguing option, especially given its impressive potential upside of 44.97%. As a prominent..
Harrow, Inc. (HROW), a pivotal player in the healthcare sector, is gaining significant attention from investors due to its strong potential for growth. The company, headquartered in Nashville, Tennessee, specializes..
GoodRx Holdings, Inc. (NASDAQ: GDRX) presents a compelling opportunity for investors seeking exposure in the health information services sector, known for its innovative approach to healthcare costs in the United..
Vera Therapeutics, Inc. (NASDAQ: VERA), a clinical-stage biotechnology company, is catching the eye of investors with its ambitious approach to tackling serious immunological diseases. With a market capitalization of $1.58..
agilon health, inc. (NYSE: AGL) presents an intriguing proposition for investors focused on the healthcare sector, particularly given its role in transforming senior care. The company operates at the intersection..
Bausch Health Companies Inc. (NYSE: BHC), a prominent name in the healthcare sector, continues to be a focal point for investors keen on specialty and generic drug manufacturing. Headquartered in..
Pediatrix Medical Group, Inc. (NYSE: MD), a prominent player in the healthcare sector, specifically within medical care facilities, is drawing attention from investors due to its modest market cap of..
Travere Therapeutics, Inc. (NASDAQ: TVTX) is garnering significant attention among investors, primarily due to its considerable potential upside. With a target price range that suggests a 65.09% increase from its..
Immunocore Holdings plc (NASDAQ: IMCR), a prominent player in the biotechnology sector, has been capturing investor attention with its innovative approach to immunotherapy. Headquartered in Abingdon, United Kingdom, the company..
Dynavax Technologies Corporation (NASDAQ: DVAX) stands out in the healthcare sector, not just for its innovative vaccine technologies but also for its intriguing investment potential. With a market capitalization of..
Celldex Therapeutics, Inc. (NASDAQ: CLDX), a biopharmaceutical company with a focus on developing therapeutic antibodies for severe inflammatory and autoimmune diseases, presents a compelling case for investors seeking high-growth opportunities..
Investors monitoring the healthcare sector should take a closer look at Janux Therapeutics, Inc. (NASDAQ: JANX), a clinical-stage biopharmaceutical firm specializing in innovative cancer treatments. With a market capitalization of..
Artivion, Inc. (NASDAQ: AORT) stands out in the competitive healthcare landscape, particularly within the medical devices industry. With a market capitalization of $2.05 billion, this U.S.-based company is making significant..
Vericel Corporation (VCEL), a dynamic player in the biotechnology sector, presents a compelling case for investors with a notable potential upside of 62.18%. This commercial-stage biopharmaceutical company, headquartered in Cambridge,..
CONMED Corporation (NASDAQ: CNMD) is a noteworthy player in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $1.67 billion, this U.S.-based company is recognized..
Supernus Pharmaceuticals, Inc. (SUPN), a key player in the biopharmaceutical sector, is making strides in the treatment of central nervous system (CNS) diseases. With a robust portfolio that includes Qelbree..
Progyny, Inc. (NASDAQ: PGNY), a notable player in the healthcare sector, specializes in fertility and family-building benefits solutions across the United States. With a market capitalization of $1.96 billion, Progyny..
SS Innovations International Inc. (SSII), a trailblazer in the medical devices industry, has garnered attention with its impressive 121.8% revenue growth. Operating from its headquarters in Gurugram, India, SSII is..
Wave Life Sciences Ltd. (NASDAQ: WVE) is making waves in the biotechnology sector with its innovative approach to RNA medicine. The Singapore-based company, with a market cap of $1.21 billion,..
Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) is capturing the attention of investors with its robust 43.28% potential upside, as evidenced by the average target price of $38.56 set by analysts. As..
